1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,855 | 2,150 | 21.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Bioretec Ltd's schedule for financial reporting in 2025 | 1 | Cision News | ||
| 12.12. | The Finnish Financial Supervisory Authority has imposed a penalty payment on a member of Bioretec's Board of Directors for late notification of managers' transactions | 2 | Cision News | ||
| 29.11. | Correction: Bioretec Ltd - Managers' transactions - Stephen Industries Inc Oy | 1 | Cision News | ||
| 29.11. | Bioretec Ltd - Managers' transactions - Poutiainen | 2 | Cision News | ||
| 28.11. | Bioretec Ltd: 3,000,000 new shares registered with the trade register | 1 | Cision News | ||
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 27.11. | Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million | 2 | Cision News | ||
| 27.11. | Inside information: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 5 million through a private placement of new shares | - | Cision News | ||
| 22.11. | Bioretec signs new distro deal for biodegradable orthopedic implants in the U.S. | 2 | MassDevice | ||
| 22.11. | Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs Trauma Screw in the U.S. civilian hospital market | 246 | PR Newswire | Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET
TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic... ► Artikel lesen | |
| 20.11. | The commercialization of Bioretec's RemeOs Trauma Screw in the U.S. proceeds with the signing of new logistics agreement | 432 | PR Newswire | Bioretec Ltd Press release 20 November 2024 at 3:30 p.m. EET
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic... ► Artikel lesen | |
| 14.11. | Bioretec Ltd's business review January-September 2024: Launch of the RemeOs Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage | 114 | PR Newswire | Bioretec Ltd Company announcement 14 November 2024 at 8:45 a.m.
TAMPERE, Finland, Nov. 14, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-September... ► Artikel lesen | |
| 04.10. | Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs Spinal Interbody Cage | 359 | PR Newswire | TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec updates its product development strategy by accelerating the product development of the RemeOs Spinal Interbody Cage, an innovative... ► Artikel lesen | |
| 04.10. | Inside information: Bioretec updates its financial targets | 304 | PR Newswire | Bioretec Ltd Company announcement 4 October 2024 at 2:31 p.m. EEST
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec Ltd announced today, 4 October 2024, that Bioretec's board... ► Artikel lesen | |
| 20.09. | Bioretec's Shareholders' Nomination Board appointed | 312 | PR Newswire | TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ -- The following persons have been appointed to Bioretec's Shareholders' Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries... ► Artikel lesen | |
| 15.08. | Bioretec Ltd's half-year report January-June 2024: RemeOs trauma screw controlled launch in the U.S. yielded expected positive clinical results | 402 | PR Newswire | Bioretec Ltd Company announcement 15 August 2024 at 8:00 a.m.
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ -- This announcement is a summary of Bioretec Ltd's half-year report January-June... ► Artikel lesen | |
| 27.06. | Inside Information: Update for Bioretec's RemeOs Trauma Screw European Marketing Authorization | 239 | PR Newswire | TAMPERE, Finland, June 27, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, announces that according to the information received from the Notified Body... ► Artikel lesen | |
| 19.06. | Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs trauma screw: fracture healing confirmed in 100% of surgical procedures | 551 | PR Newswire | TAMPERE, Finland, June 19, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of cases have been performed around the... ► Artikel lesen | |
| 18.06. | Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team | 374 | PR Newswire | Bioretec Ltd Press release 18 June 2024 at 9:00 a.m. EEST
TAMPERE, Finland, June 18, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneer in biodegradable orthopedic implants, has, as of June... ► Artikel lesen | |
| 20.05. | Inside information: Alan Donze has been appointed as Bioretec's new CEO | 338 | PR Newswire | Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST
TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed... ► Artikel lesen | |
| 16.05. | Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses | 324 | PR Newswire | Bioretec Ltd Company announcement 16 May 2024 at 8:30 a.m.
TAMPERE, Finland, May 16, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 45,800 | 0,00 % | Carl Zeiss Meditec-Aktie leicht im Minus (45,54 €) | Das Wertpapier von Carl Zeiss Meditec notiert am Freitag ein wenig leichter. Das Papier kostete zuletzt 45,54 Euro. Der Anteilsschein von Carl Zeiss Meditec verzeichnet zur Stunde einen Kursrückgang... ► Artikel lesen | |
| ECKERT & ZIEGLER | 44,580 | +0,41 % | Eckert&Ziegler-Aktionäre aufgepasst: Könnte die Aktie am Montag komplett einbrechen - Das müssen Sie JETZT beachten! | ||
| GERRESHEIMER | 67,65 | -7,27 % | EQS-News: Gerresheimer AG: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU* | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Zulassungsantrag
Gerresheimer: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU*
16.12.2024 / 09:00... ► Artikel lesen | |
| CYTOSORBENTS | 0,814 | -6,86 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
| OPTOMED | 4,185 | -0,12 % | Optomed Oyj: Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook | Optomed Plc Inside Information 11 November 2024 at 21.00, Helsinki
Inside information, profit warning: Optomed receives a large order in the US and increases its full... ► Artikel lesen | |
| FRESENIUS | 33,200 | -0,84 % | Fresenius SE Aktie: Positiver Umsatztrend! | Die Fresenius SE-Aktie zeigt sich im aktuellen Handelsverlauf an der XETRA mit wechselhafter Tendenz. Nach einem Handelsstart bei 34,92 EUR bewegte sich der Kurs im Tagesverlauf zwischen verschiedenen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,10 | -0,72 % | Nach Siemens-Energy-Boom: Startet als nächstes die Siemens-Healthineers-Aktie durch? | Ein starkes Schlussquartal und ein optimistischer Ausblick des Medizintechnikers Siemens Healthineers sollten der Aktie genug Rückenwind liefern, auf den Anleger gehebelt setzen können. So funktioniert's.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,880 | -0,05 % | Neue 9,50% Aktienanleihe mit Barriere auf Fresenius Medical Care in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC95GD8/ WKN VC95GD) mit Barriere auf die Aktie von Fresenius... ► Artikel lesen | |
| LIFEMD | 5,040 | +3,07 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,90 | -0,02 % | $100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today | ||
| TEMPUS AI | 35,500 | +7,48 % | Tempus AI CEO Eric Lefkofsky verkauft Aktien im Wert von 7 Millionen US-Dollar | ||
| UNITEDHEALTH | 480,00 | +0,03 % | UnitedHealth - UNH: Der Versicherungskonzern stemmt sich gegen den Abverkauf! | Sprudelnde Gewinne, aber unzufriedene Kunden bei UnitedHealth (UNH)! CEO Brian Thompson ermordet! Was nun? UnitedHealth (UNH) - ISIN US91324P1021 Rückblick: Aufgrund der Verunsicherung der Anleger nach... ► Artikel lesen | |
| THERMO FISHER | 500,50 | -0,38 % | Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific | LAKEWOOD, N.J.--(BUSINESS WIRE)--Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,930 | -0,68 % | Hims & Hers Stock: Growth, Noise, and Where to Focus Now | ||
| BRIGHTSPRING HEALTH SERVICES | 17,260 | +1,29 % | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen |
BIORETEC OY gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,00 % bei einem Aktienkurs von 1,970 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.
